Patent application number | Description | Published |
20140221682 | SYNTHESIS AND BIOLOGICAL STUDIES OF AN ISOMERIC MIXTURE OF (E/Z) ISOXYLITONES AND ITS ANALOGUES - The invention relates to an anti-epileptic isoxylitone, 2,2′-(3,5,5-Trimethyl-2-cyclohexen-1-ylidene) acetic acid. | 08-07-2014 |
20140256754 | QUINAZOLINES AS B-GLUCURONIDASE NOVEL INHIBITORS - Quinazoline derivatives 1-25, (2-[3,4-bis(methyloxy)phenyl]quinazolin-4-(3H)-one) and 2-[2-(ethyloxy)phenyl]quinazoline-4-(3H)-one) are reported as β-glucuronidase inhibitors useful in the treatment of β-glucuronidase hyperactivity disorders. | 09-11-2014 |
20150038543 | ANTI-GLYCATION PROPERTIES OF OXINDOLE DERIVATIVES - This invention provides a series of new oxindole derivatives 1-21, evaluated for their antiglycation potential by using in vitro BSA-MG glycation model. These derivatives showed a varying degree of antiglycation activity with IC | 02-05-2015 |
20150051286 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION - Anthranilic acid derivatives are used to inhibit the formation of advanced glycation end products to reduce complications in diabetes. | 02-19-2015 |
20150080580 | THIOUREA DERIVATIVES AS a-CHYMOTRYPSIN INHIBITORS - α-Chymotrypsin inhibitors of thiourea class are reported that could be potent inhibitors of proteases, elastases, proteasomes, NS3 and NS4 serine protease of hepatitis C virus, dengue virus, etc. Compounds | 03-19-2015 |
20150148417 | SYNTHESIS AND BIOLOGICAL STUDIES OF AN ISOMERIC MIXTURE OF (E/Z) ISOXYLITONES AND ITS ANALOGUES - The invention relates to an anti-epileptic isoxylitone, 2,2′-(3,5,5-Trimethyl-2-cylohexen-1-ylidene)acetic acid. | 05-28-2015 |
20150335594 | THIOUREA DERIVATIVES - Two thiourea derivatives N-(3-chlorophenyl)-N′-(3,4-difluorophenyl) thiourea and N-(3-chlorophenyl)-N-(3-methoxyphenyl)-thiourea are reported as treatment of multidrug resistance infections from | 11-26-2015 |
20150368214 | SCHIFF BASES OF THIAZOLES: A NEW CLASS OF UREASES INHIBITORS - One embodiment of the invention relates to treating diseases associated with increased urease enzyme activity comprising administering an effective amount of a compound selected from a group consisting of 28 thiazoles Schiff bases. Kinetic studies were performed on ten (10) of the most active compounds. | 12-24-2015 |